Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,011 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial.
Zheng Y, Ching J, Cheng CW, Lam WC, Chan KL, Zhang X, Lam PY, Wu XY, Zhong LLD, Cao PH, Lo CW, Cheong PK, Lin Z, Koh M, Wu J, Bian ZX. Zheng Y, et al. Among authors: chan kl. Chin Med. 2021 Nov 13;16(1):117. doi: 10.1186/s13020-021-00530-2. Chin Med. 2021. PMID: 34774080 Free PMC article.
A Chinese Medicine Formula (Bushen Huoxue Tongluo) for the Treatment of Chronic Subjective Tinnitus: A Study Protocol for a Pilot, Assessor-Blinded, Randomized Clinical Trial.
Zhang HW, Yeung KNK, Tong MCF, Lin ZX, Chang WWT, Ng IH, Sum CH, Leung KC, Chan KL, Ngan K, Tong TJ. Zhang HW, et al. Among authors: chan kl. Front Pharmacol. 2022 Mar 30;13:844730. doi: 10.3389/fphar.2022.844730. eCollection 2022. Front Pharmacol. 2022. PMID: 35431960 Free PMC article.
The efficacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trial.
Cheong PK, Ho TM, Chan KL, Lo CW, Leung SB, Hon KL, Leung KC, Siu THC, Song TH, Zhang H, Ching JYL, Chow TY, Sum CH, Chia CP, Lin ZX. Cheong PK, et al. Among authors: chan kl. Front Pharmacol. 2022 Dec 16;13:1058176. doi: 10.3389/fphar.2022.1058176. eCollection 2022. Front Pharmacol. 2022. PMID: 36588672 Free PMC article.
Chinese medicine for residual symptoms of COVID-19 recovered patients (long COVID)-A double-blind, randomized, and placebo-controlled clinical trial protocol.
Sum CH, Ching JYL, Song T, Cheong PK, Lo CW, Lai MK, Chia CP, Chan KL, Mak WY, Leung KC, Leung SB, Zhang H, Lin Z. Sum CH, et al. Among authors: chan kl. Front Med (Lausanne). 2023 Jan 4;9:990639. doi: 10.3389/fmed.2022.990639. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36687403 Free PMC article.
Corrigendum: A Chinese medicine formula (Bushen Huoxue Tongluo) for the treatment of chronic subjective tinnitus: a study protocol for a pilot, assessor-blinded, randomized clinical trial.
Zhang HW, Yeung KNK, Tong MCF, Lin ZX, Chang WWT, Ng IH, Sum CH, Leung KC, Chan KL, Ngan K, Tong TJ. Zhang HW, et al. Among authors: chan kl. Front Pharmacol. 2023 Sep 7;14:1258855. doi: 10.3389/fphar.2023.1258855. eCollection 2023. Front Pharmacol. 2023. PMID: 37745086 Free PMC article.
1,011 results